Tasly Pharmaceutical Group Co Ltd
SSE:600535
Dividends
Dividend Yield
Tasly Pharmaceutical Group Co Ltd
| Current Yield | |
| Min Yield | |
| Max Yield | |
| Average Yield | |
| Median Yield |
Dividend Per Share
Tasly Pharmaceutical Group Co Ltd
Tasly Pharmaceutical Group Co Ltd have
decreased
by 0%.
Payout Ratio
Tasly Pharmaceutical Group Co Ltd
Peers Comparison
Dividends
Shareholder Yield
Current shareholder yield for Tasly Pharmaceutical Group Co Ltd is
hidden
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
Price
Tasly Pharmaceutical Group Co Ltd
| Average Annual Return | 6.37% |
| Standard Deviation of Annual Returns | 38.9% |
| Max Drawdown | -42% |
| Market Capitalization | 21.9B CNY |
| Shares Outstanding | 1 493 950 000 |
| Percentage of Shares Shorted |
N/A
|
Return Decomposition
Main factors of price return
Stock Splits
Tasly Pharmaceutical Group Co Ltd's latest stock split occurred on Jun 5, 2018
The company executed a 7-for-5 stock split, meaning that for every 5 shares held, investors received 7 new shares.
Before the split, Tasly Pharmaceutical Group Co Ltd traded at 39.6101 per share. Afterward, the share price was about 25.7524.
The adjusted shares began trading on Jun 5, 2018. This was Tasly Pharmaceutical Group Co Ltd's 4th stock split, following the previous one in May 22, 2013.
